Pilot Trial: Bioavailability Animal vs. Plant Protein Drink

NCT ID: NCT06465004

Last Updated: 2024-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-08

Study Completion Date

2024-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A pilot study is being conducted to compare a new plant-based protein drink to commercially available animal-based protein drinks. The goal is to assess if the plant-based drink delivers amino acids to the bloodstream as effectively as the animal-based drinks, potentially offering a viable option for those on plant-based diets.

The study will involve approximately 12 healthy adults aged 18-40. Each participant will try all three drinks (the new plant-based drink, a commercial animal-based drink, and another animal-based recipe) on separate days in a randomized order. Before and after (30, 60, and 90 minutes) consuming each drink, a small blood sample will be drawn to measure amino acid levels (leucine).

By comparing the results, the investigators hope to determine if the plant-based drink can match the effectiveness of animal-based protein drinks in delivering essential nutrients. This research could contribute to the development of sustainable and nutritious plant-based protein alternatives.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition, Healthy Leucine Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized cross-over design
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Animal-based A

A commercially available high protein drink, based on animal proteins (Fresubin Protein Energy)

Group Type ACTIVE_COMPARATOR

Consumption of protein - rich drink

Intervention Type DIETARY_SUPPLEMENT

The participants will drink on of three protein - rich drinks

Animal-based B

A homemade drink containing animal-based proteins, using a specific animal-based protein isolate mix.

Group Type ACTIVE_COMPARATOR

Consumption of protein - rich drink

Intervention Type DIETARY_SUPPLEMENT

The participants will drink on of three protein - rich drinks

Plant-based A

A homemade drink containing plant-based proteins, formulated to have the same macronutrient content as the animal-based drinks.

Group Type ACTIVE_COMPARATOR

Consumption of protein - rich drink

Intervention Type DIETARY_SUPPLEMENT

The participants will drink on of three protein - rich drinks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Consumption of protein - rich drink

The participants will drink on of three protein - rich drinks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gender: male and female
* Age: 18-40 years
* Signed written informed consent

Exclusion Criteria

* Smoking history
* Cardiovascular diseases
* BMI \> 35 kg/m2
* Caffeine consumption \< 1 day before the study participation
* Allergies: Soy, Peas, Milk, Lactose, Fructose
* High intensity exercise \<2 days before study participation
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ETH Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gommaar D'Hulst, PhD

Role: PRINCIPAL_INVESTIGATOR

ETH Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SLA - ETH Zurich

Schwerzenbach, Canton of Zurich, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gommaar D'Hulst, PhD

Role: CONTACT

+41786624474

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Katrien De Bock, PhD

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-00151

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Milk and Plant Protein Digestion
NCT06272331 COMPLETED NA
Spoonable Bioavailability
NCT06733142 COMPLETED NA